With over 90% absorption, our formula outperforms traditional oral peptides and even injectable optionswithout the needles, pain, or complicated dosing
However, most current studies rely solely on the EAE mouse model and the LPC-induced localized myelin loss model, which do not fully recapitulate the complex pathological features of MS, particularly its heterogeneity, disease progression, and clinical symptoms
The component peptides have demonstrated wide safety margins in preclinical and early clinical studies [3] [4] [5]
While oral supplements are commonly thought to provide the necessary vitamins and nutrients, their absorption can be limited due to imperfect digestive processes and individual variations
This may indicate that the visual improvement from hair count alone (without thickness changes) fell short of patient expectations